ADAR1 Partners, LP 的 Form 4 申報
Keros Therapeutics, Inc.（KROS），2025/4/11 申報
- 申報編號
- 0001104659-25-034321
- 申報時間
- 2025/4/11 21:57 ET
- 交易日
- 2025/4/9
- 申報延遲
- 2 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 5 筆非衍生性交易、3 筆衍生性交易。公開市場買進合計 $946.5 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| ADAR1 Partners, LPCIK 0001758866 | 持股 10% 以上大股東 |
| Schneeberger DanielCIK 0001861120 | 持股 10% 以上大股東 |
| ADAR1 Capital Management GP, LLCCIK 0001940267 | 持股 10% 以上大股東 |
| ADAR1 Capital Management, LLCCIK 0001940272 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2025/4/9 | Common Stock | P買進取得 | +18,560 | $9.40F2 | +$174,374.91 | 3,493,404 | 間接 | |
| 2025/4/9 | Common Stock | P買進取得 | +16,365 | $9.40F3 | +$153,752.45 | 743,558 | 間接 | |
| 2025/4/9 | Common Stock | P買進取得 | +325,000 | $9.86F4 | +$3,203,525 | 3,818,404 | 間接 | |
| 2025/4/9 | Common Stock | P買進取得 | +500,000 | $10.33 | +$5,165,000 | 4,318,404 | 間接 | |
| 2025/4/9 | Common Stock | P買進取得 | +74,333 | $10.33 | +$767,859.89 | 4,392,737 | 間接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.21 to $9.56, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F3
The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.21 to $9.56, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.13 to $10.60, inclusive.
表 I 有 1 筆交易的價格引用這則附註。
- F5
In connection with the purchase of 325,000 securities reported as being purchased in Table 1, ADAR1 Partners, LP and the counterparty to the cash-settled total equity swaps previously reported agreed to reduce the number of notional shares of Common Stock of the Issuer in the applicable basket by a corresponding number of 325,000 shares. As a result, the aggregate number of notional shares of Common Stock of the Issuer in the applicable basket after giving effect to such transactions is 624,333 shares.
表 II 有 1 筆交易的價格引用這則附註。
- F6
In connection with the purchase of 500,000 securities reported as being purchased in Table 1, ADAR1 Partners, LP and the counterparty to the cash-settled total equity swaps previously reported agreed to reduce the number of notional shares of Common Stock of the Issuer in the applicable basket by a corresponding number of 500,000 shares. As a result, the aggregate number of notional shares of Common Stock of the Issuer in the applicable basket after giving effect to such transactions is 124,333 shares.
表 II 有 1 筆交易的價格引用這則附註。
- F7
In connection with the purchase of 74,333 securities reported as being purchased in Table 1, ADAR1 Partners, LP and the counterparty to the cash-settled total equity swaps previously reported agreed to reduce the number of notional shares of Common Stock of the Issuer in the applicable basket by a corresponding number of 74,333 shares. As a result, the aggregate number of notional shares of Common Stock of the Issuer in the applicable basket after giving effect to such transactions is 50,000 shares.
表 II 有 1 筆交易的價格引用這則附註。